Comments
Loading...
Eupraxia Pharmaceuticals Stock Price, Quotes and Forecasts
EPRXNASDAQ
Eupraxia Pharmaceuticals (EPRX) Forecast
NewsEarningsEupraxia Pharmaceuticals (EPRX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Eupraxia Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:EPRX | Benzinga
Explore Eupraxia Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for EPRX.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Eupraxia Pharmaceuticals (EPRX) stock?
You can purchase shares of Eupraxia Pharmaceuticals (NASDAQ:EPRX) through any online brokerage.
Who are Eupraxia Pharmaceuticals (EPRX) competitors?
There are no as such competitors for Eupraxia Pharmaceuticals.
What is the forecast, or price target, for Eupraxia Pharmaceuticals (EPRX) stock?
Eupraxia Pharmaceuticals has a consensus price target of $9.00.
What is the current price for Eupraxia Pharmaceuticals (EPRX)?
The stock price for Eupraxia Pharmaceuticals (NASDAQ: EPRX) is $4.43 last updated March 17, 2025 at 9:28 AM EDT.
Does Eupraxia Pharmaceuticals (EPRX) pay a dividend?
There are no upcoming dividends for Eupraxia Pharmaceuticals.
When is Eupraxia Pharmaceuticals (NASDAQ:EPRX) reporting earnings?
Eupraxia Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
Is Eupraxia Pharmaceuticals (EPRX) going to split?
There is no upcoming split for Eupraxia Pharmaceuticals.
What sector and industry does Eupraxia Pharmaceuticals (EPRX) operate in?
Eupraxia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.